chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: a nurse inadvertently gave a dose of the Moderna COVID19 vaccine to 17 year old patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a nurse inadvertently gave a dose of the Moderna COVID19 vaccine to 17 year old patient) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Shellfish allergy. Concomitant products included MELATONIN, AMITRIPTYLINE and NORTRIPTYLINE for an unknown indication.    On 29-Jul-2021 at 9:33 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a nurse inadvertently gave a dose of the Moderna COVID19 vaccine to 17 year old patient). On 29-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a nurse inadvertently gave a dose of the Moderna COVID19 vaccine to 17 year old patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Sep-2021: Follow-up information contains height, weight, race of the patient added, medical history added. Batch number and anatomical location  of the drug added
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site erythema, Injection site pruritus, Injection site warmth, Pain in extremity
Clinical narrative: Really bad pain in her right leg, pain in the foot, barely any pain in her left leg; Pain in the ankle; Injection area is red; Injection area is hot to the touch; Injection area itches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Really bad pain in her right leg, pain in the foot, barely any pain in her left leg), ARTHRALGIA (Pain in the ankle), INJECTION SITE ERYTHEMA (Injection area is red), INJECTION SITE WARMTH (Injection area is hot to the touch) and INJECTION SITE PRURITUS (Injection area itches) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A and 006D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Really bad pain in her right leg, pain in the foot, barely any pain in her left leg), ARTHRALGIA (Pain in the ankle), INJECTION SITE ERYTHEMA (Injection area is red), INJECTION SITE WARMTH (Injection area is hot to the touch) and INJECTION SITE PRURITUS (Injection area itches). At the time of the report, PAIN IN EXTREMITY (Really bad pain in her right leg, pain in the foot, barely any pain in her left leg), ARTHRALGIA (Pain in the ankle), INJECTION SITE ERYTHEMA (Injection area is red), INJECTION SITE WARMTH (Injection area is hot to the touch) and INJECTION SITE PRURITUS (Injection area itches) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-304337.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site). At the time of the report, VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown.            No concomitant medications was provided by the reporter. No treatment was provided by the reporter.   This case was linked to MOD-2021-303933 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Diarrhoea, Eye discharge, Illness
Clinical narrative: Sick; Diarrhea; Mucus-y eyes; Tightness in my chest; Cough; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), DIARRHOEA (Diarrhea), EYE DISCHARGE (Mucus-y eyes), CHEST DISCOMFORT (Tightness in my chest) and COUGH (Cough) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, the patient experienced COUGH (Cough). On an unknown date, the patient experienced ILLNESS (Sick), DIARRHOEA (Diarrhea), EYE DISCHARGE (Mucus-y eyes) and CHEST DISCOMFORT (Tightness in my chest). At the time of the report, ILLNESS (Sick), DIARRHOEA (Diarrhea), EYE DISCHARGE (Mucus-y eyes), CHEST DISCOMFORT (Tightness in my chest) and COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported. Treatment information was not reported. The patient states she got sick in July; she did not have COVID. She had three tests done between 07Jul2021 and 18Jul2021, and they were all negative.
Sex: U
Vaccine: COVID19
Symptoms: Ageusia, Vaccination complication
Clinical narrative: loss of taste; started coming down with symptoms of the virus; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste) and VACCINATION COMPLICATION (started coming down with symptoms of the virus) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste) and VACCINATION COMPLICATION (started coming down with symptoms of the virus). At the time of the report, AGEUSIA (loss of taste) and VACCINATION COMPLICATION (started coming down with symptoms of the virus) outcome was unknown.            The treatment history was not reported. The concomitant medication was not reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Dysgeusia, Hunger, Hypoaesthesia, Weight increased
Clinical narrative: doesn't have taste buds; everything tastes salty; gained weight; feels hungry all the time; her face feels numb or weird; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (doesn't have taste buds), DYSGEUSIA (everything tastes salty), WEIGHT INCREASED (gained weight), HUNGER (feels hungry all the time) and HYPOAESTHESIA (her face feels numb or weird) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A2A) for COVID-19 vaccination.     The medical history was not provided by the reporter  Concomitant products included VITAMINS NOS for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (doesn't have taste buds), DYSGEUSIA (everything tastes salty), WEIGHT INCREASED (gained weight), HUNGER (feels hungry all the time) and HYPOAESTHESIA (her face feels numb or weird). At the time of the report, AGEUSIA (doesn't have taste buds), DYSGEUSIA (everything tastes salty), WEIGHT INCREASED (gained weight) and HUNGER (feels hungry all the time) outcome was unknown and HYPOAESTHESIA (her face feels numb or weird) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications include Diabetic Medication Patient did not received any Treatment
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Systemic lupus erythematosis, Immunosuppression NOS (Chronically immunosuppressed) and Heart disease, unspecified. Concomitant products included PREDNISONE, MIRTAZAPINE, ROSUVASTATIN, WARFARIN and LISINOPRIL for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.            No treatment medications were reported.  Concurrent medical conditions also included lupus related kidney disease.   This case was linked to MOD-2021-304558, MOD-2021-304574 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore hip after first shot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore hip after first shot) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Mastectomy. Concurrent medical conditions included Cancer and Bursitis.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced MYALGIA (Sore hip after first shot). On 18-Jan-2021, MYALGIA (Sore hip after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown  The patient was under Radiation therapy. She was immunocompromised and would like to get a booster (3rd shot) in the hip.   This case was linked to MOD-2021-304564 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: caller stated that there was a 2 month gap between both doses/ 1st dose received in Feb2021/ 2nd dose received in Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller stated that there was a 2 month gap between both doses/ 1st dose received in Feb2021/ 2nd dose received in Apr2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller stated that there was a 2 month gap between both doses/ 1st dose received in Feb2021/ 2nd dose received in Apr2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller stated that there was a 2 month gap between both doses/ 1st dose received in Feb2021/ 2nd dose received in Apr2021) had resolved.            No concomitant medications were provided by reporter. No treatment details were provided by reporter. The caller asked how he could obtain a vaccination card?   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Extra dose administered, Pain in extremity
Clinical narrative: Diarrhea; Extra Dose administered; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), EXTRA DOSE ADMINISTERED (Extra Dose administered) and PAIN IN EXTREMITY (Sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), EXTRA DOSE ADMINISTERED (Extra Dose administered) and PAIN IN EXTREMITY (Sore arm). At the time of the report, DIARRHOEA (Diarrhea), EXTRA DOSE ADMINISTERED (Extra Dose administered) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case reported by an other healthcare professional, describes the occurrence of product dose omission issue (has been more than 42 days since the first dose) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. April 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced product dose omission issue (has been more than 42 days since the first dose). At the time of the report, product dose omission issue (has been more than 42 days since the first dose)  resolved. The reporter did not provide any causality assessments, concomitant medications or treatment information. Most recent follow-up information incorporated: On Sep 6, 2021: Follow-up information received included no new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Ear pain, Myalgia, Pyrexia
Clinical narrative: ear pain; fever of 104 F; body aches; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear pain), PYREXIA (fever of 104 F) and MYALGIA (body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced EAR PAIN (ear pain), PYREXIA (fever of 104 F) and MYALGIA (body aches). At the time of the report, EAR PAIN (ear pain), PYREXIA (fever of 104 F) and MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Aug-2021, Body temperature: 104 f (High) fever of 104 F.         No concomitant medications reported.  Treatment information not reported.   This case was linked to MOD-2021-304459 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Rash, Vaccination site swelling
Clinical narrative: Warm; Itchy; Red; Rash/bumpy; Swollen; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm), PRURITUS (Itchy), ERYTHEMA (Red), RASH (Rash/bumpy) and the first episode of VACCINATION SITE SWELLING (Swollen) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051e21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Warm), PRURITUS (Itchy), ERYTHEMA (Red), RASH (Rash/bumpy), the first episode of VACCINATION SITE SWELLING (Swollen) and the second episode of VACCINATION SITE SWELLING (Swollen). At the time of the report, FEELING HOT (Warm), PRURITUS (Itchy), ERYTHEMA (Red), RASH (Rash/bumpy) and the last episode of VACCINATION SITE SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.  Patient went to the pharmacy and she was told that she might have been experiencing a reaction and that she should have taken a Benadryl.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity
Clinical narrative: Sore arm; Felt achy; Headache; Chills for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Felt achy), CHILLS (Chills for 24 hours) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Felt achy), CHILLS (Chills for 24 hours) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Felt achy) and HEADACHE (Headache) outcome was unknown and CHILLS (Chills for 24 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications were not reported. The patient did not receive any treatment for the symptoms and reported as "no" for concomitant medications.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine administered after beeing in the fridge for 40 days; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (vaccine administered after beeing in the fridge for 40 days) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine administered after beeing in the fridge for 40 days). At the time of the report, PRODUCT STORAGE ERROR (vaccine administered after beeing in the fridge for 40 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Stored  in the fridge for 40 days so 10 days over our recommended storage; Vaccine  administered after being in the fridge for 40 days; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Stored  in the fridge for 40 days so 10 days over our recommended storage) and EXPIRED PRODUCT ADMINISTERED (Vaccine  administered after being in the fridge for 40 days) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 31-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced PRODUCT STORAGE ERROR (Stored  in the fridge for 40 days so 10 days over our recommended storage) and EXPIRED PRODUCT ADMINISTERED (Vaccine  administered after being in the fridge for 40 days). On 31-Aug-2021, PRODUCT STORAGE ERROR (Stored  in the fridge for 40 days so 10 days over our recommended storage) and EXPIRED PRODUCT ADMINISTERED (Vaccine  administered after being in the fridge for 40 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: This report refers to a case of Product storage error and Expired product administered for mRNA-1273, lot # 040C21A in a immunocompromised patient (third dose)  with no associated AEs. Causality is Not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Eyelid thickening, Impaired ability to use machinery, Ocular discomfort
Clinical narrative: still unable to wear her contacts; felt like something was in her left eye; bumps under her eyelid like an allergic reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of IMPAIRED ABILITY TO USE MACHINERY (still unable to wear her contacts), OCULAR DISCOMFORT (felt like something was in her left eye) and EYELID THICKENING (bumps under her eyelid like an allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Contact lens wearer.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced IMPAIRED ABILITY TO USE MACHINERY (still unable to wear her contacts), OCULAR DISCOMFORT (felt like something was in her left eye) and EYELID THICKENING (bumps under her eyelid like an allergic reaction). At the time of the report, IMPAIRED ABILITY TO USE MACHINERY (still unable to wear her contacts) had not resolved and OCULAR DISCOMFORT (felt like something was in her left eye) and EYELID THICKENING (bumps under her eyelid like an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On 01-Sep-2021, Patient stated that she got her first Moderna vaccine about 4 weeks ago and was due for the second shot on 02-Sep-2021.  After 5-6 hours of vaccine she felt something in her eye and removed her contacts and wore her glasses. Her eye doctor after assessing gave her a lubricant.   No relevant concomitant medications were reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fatigue; Body aches / Muscle Pain; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Body aches / Muscle Pain), CHILLS (Chills) and PYREXIA (Fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A and 039C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Body aches / Muscle Pain), CHILLS (Chills) and PYREXIA (Fever). On 31-Aug-2021, PYREXIA (Fever) had resolved. At the time of the report, FATIGUE (Fatigue), MYALGIA (Body aches / Muscle Pain) and CHILLS (Chills) outcome was unknown.            patient stated fever occurred only last night and does not have fever that day. Concomitant medications were not provided. Treatment includes intake of lot of fluids.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered Expired Vaccine to a patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine to a patient) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039C21A and 039C21A) for COVID-19 vaccination.     No Medical History information was reported.   In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine to a patient). On 29-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine to a patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Product dose omission issue, Vaccination complication
Clinical narrative: Reaction not he first dose; Arm swelled; arm was red and painful for a few days; arm was red and painful for a few days; Did not take the second shot due to this reaction; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Reaction not he first dose), PERIPHERAL SWELLING (Arm swelled), ERYTHEMA (arm was red and painful for a few days), PAIN IN EXTREMITY (arm was red and painful for a few days) and PRODUCT DOSE OMISSION ISSUE (Did not take the second shot due to this reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction not he first dose), PERIPHERAL SWELLING (Arm swelled), ERYTHEMA (arm was red and painful for a few days), PAIN IN EXTREMITY (arm was red and painful for a few days) and PRODUCT DOSE OMISSION ISSUE (Did not take the second shot due to this reaction). At the time of the report, VACCINATION COMPLICATION (Reaction not he first dose), PERIPHERAL SWELLING (Arm swelled), ERYTHEMA (arm was red and painful for a few days) and PAIN IN EXTREMITY (arm was red and painful for a few days) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not take the second shot due to this reaction) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.
Age: 13.0
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products, Product administered to patient of inappropriate age
Clinical narrative: Patient received Pfizer as a 1st dose and Moderna as 2nd dose; a 13-year-old patient received Moderna as a 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old patient received Moderna as a 2nd dose) and INTERCHANGE OF VACCINE PRODUCTS (Patient received Pfizer as a 1st dose and Moderna as 2nd dose) in a 13-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 01-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On 01-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old patient received Moderna as a 2nd dose). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received Pfizer as a 1st dose and Moderna as 2nd dose). On 01-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old patient received Moderna as a 2nd dose) had resolved. At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient received Pfizer as a 1st dose and Moderna as 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Got 2nd dose beyond 35 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose beyond 35 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose beyond 35 days). On 08-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose beyond 35 days) had resolved.            Concomitant medications was not provided by the reporter Treatment information was not provided
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Headache, Illness, Myalgia
Clinical narrative: loss sense of smell; . Patient reported being sick; really bad body aches; experiencing headache; missed dose; test positive for Covid 19 / she eventually found out was Covid; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed dose), COVID-19 (test positive for Covid 19 / she eventually found out was Covid), THROAT IRRITATION (scratchy throat), ANOSMIA (loss sense of smell) and ILLNESS (. Patient reported being sick) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.  Concomitant products included ACYCLOVIR [ACICLOVIR] for Antiviral treatment, DICLOFENAC for Arthritis, LEVOFLOXACIN (LEVAQUIN) for Asthma, MONTELUKAST SODIUM (SINGULAIR) for Pneumonia, CLONAZEPAM for Sleep problem, ZINC SULFATE (LIQUID ZINC), ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) and VITAMIN D NOS for an unknown indication.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose), COVID-19 (test positive for Covid 19 / she eventually found out was Covid), ANOSMIA (loss sense of smell), ILLNESS (. Patient reported being sick), MYALGIA (really bad body aches) and HEADACHE (experiencing headache). The patient was treated with IBUPROFEN for Corona virus infection, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for COVID-19, at an unspecified dose and frequency. At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed dose) and COVID-19 (test positive for Covid 19 / she eventually found out was Covid) had resolved and THROAT IRRITATION (scratchy throat), ANOSMIA (loss sense of smell), ILLNESS (. Patient reported being sick), MYALGIA (really bad body aches) and HEADACHE (experiencing headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported she was cleared yesterday 31August2021 from Covid.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Throat irritation
Clinical narrative: loss sense of smell; . Patient reported being sick; really bad body aches; experiencing headache; missed dose; test positive for Covid 19 / she eventually found out was Covid; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed dose), COVID-19 (test positive for Covid 19 / she eventually found out was Covid), THROAT IRRITATION (scratchy throat), ANOSMIA (loss sense of smell) and ILLNESS (. Patient reported being sick) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.  Concomitant products included ACYCLOVIR [ACICLOVIR] for Antiviral treatment, DICLOFENAC for Arthritis, LEVOFLOXACIN (LEVAQUIN) for Asthma, MONTELUKAST SODIUM (SINGULAIR) for Pneumonia, CLONAZEPAM for Sleep problem, ZINC SULFATE (LIQUID ZINC), ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) and VITAMIN D NOS for an unknown indication.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose), COVID-19 (test positive for Covid 19 / she eventually found out was Covid), ANOSMIA (loss sense of smell), ILLNESS (. Patient reported being sick), MYALGIA (really bad body aches) and HEADACHE (experiencing headache). The patient was treated with IBUPROFEN for Corona virus infection, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for COVID-19, at an unspecified dose and frequency. At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed dose) and COVID-19 (test positive for Covid 19 / she eventually found out was Covid) had resolved and THROAT IRRITATION (scratchy throat), ANOSMIA (loss sense of smell), ILLNESS (. Patient reported being sick), MYALGIA (really bad body aches) and HEADACHE (experiencing headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported she was cleared yesterday 31August2021 from Covid.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Pyrexia
Clinical narrative: No appetite; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), CHILLS (Chills) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine (migraine with seeing spots), Vitamin D deficiency and Constipation. Concurrent medical conditions included Relapsing-remitting multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced DECREASED APPETITE (No appetite), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, DECREASED APPETITE (No appetite), CHILLS (Chills) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. On 20-Feb-2021, it was reported that patient experienced Undetected antibodies.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash, Rash pruritic
Clinical narrative: she developed a rash on her left arm, and now spreading to her right arm; it's itchy; few bumps on her legs; This spontaneous case was reported by a nurse and describes the occurrence of RASH (she developed a rash on her left arm, and now spreading to her right arm), RASH PRURITIC (it's itchy) and PERIPHERAL SWELLING (few bumps on her legs) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 23-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, the patient experienced RASH (she developed a rash on her left arm, and now spreading to her right arm), RASH PRURITIC (it's itchy) and PERIPHERAL SWELLING (few bumps on her legs). At the time of the report, RASH (she developed a rash on her left arm, and now spreading to her right arm), RASH PRURITIC (it's itchy) and PERIPHERAL SWELLING (few bumps on her legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient used Benadryl and Steroid cream for treatment but they didn't work.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: got Covid-19 after being vaccinated; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (got Covid-19 after being vaccinated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid-19 after being vaccinated). At the time of the report, COVID-19 (got Covid-19 after being vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Headache, Malaise, Myalgia
Clinical narrative: Felt sick; Arm hurts; Off balance; Lightheaded; Run a fever on and off; Headache; Body aches muscle aches; Nauseas if I eat something I feel like I'm going to throw up; Redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded) and PYREXIA (Run a fever on and off) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A and 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded), PYREXIA (Run a fever on and off), HEADACHE (Headache), MYALGIA (Body aches muscle aches), NAUSEA (Nauseas if I eat something I feel like I'm going to throw up) and VACCINATION SITE ERYTHEMA (Redness in the injection site). At the time of the report, MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded), PYREXIA (Run a fever on and off), HEADACHE (Headache), MYALGIA (Body aches muscle aches), NAUSEA (Nauseas if I eat something I feel like I'm going to throw up) and VACCINATION SITE ERYTHEMA (Redness in the injection site) outcome was unknown.            Concomitant medication included Medication for diabetes type 2.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: Felt sick; Arm hurts; Off balance; Lightheaded; Run a fever on and off; Headache; Body aches muscle aches; Nauseas if I eat something I feel like I'm going to throw up; Redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded) and PYREXIA (Run a fever on and off) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A and 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded), PYREXIA (Run a fever on and off), HEADACHE (Headache), MYALGIA (Body aches muscle aches), NAUSEA (Nauseas if I eat something I feel like I'm going to throw up) and VACCINATION SITE ERYTHEMA (Redness in the injection site). At the time of the report, MALAISE (Felt sick), PAIN IN EXTREMITY (Arm hurts), BALANCE DISORDER (Off balance), DIZZINESS (Lightheaded), PYREXIA (Run a fever on and off), HEADACHE (Headache), MYALGIA (Body aches muscle aches), NAUSEA (Nauseas if I eat something I feel like I'm going to throw up) and VACCINATION SITE ERYTHEMA (Redness in the injection site) outcome was unknown.            Concomitant medication included Medication for diabetes type 2.   Treatment information was not provided.
Age: 37.0
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction, Cold sweat, Dizziness, Headache, Heart rate
Clinical narrative: blurry vision; extreme dizziness; felt clammy; really bad reaction; headache,; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart disorder.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction), HEADACHE (headache,) and NAUSEA (nausea). At the time of the report, VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness) and NAUSEA (nausea) had resolved and COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Aug-2021, Heart rate: increased (High) High heart rate for 15 minutes..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided. Three minutes after the first dose, really bad reaction with high heart rate for 15 minutes, blurry vision, headache, nausea, extreme dizziness was reported. The patient was not sweating but felt clammy. The patient stated that his blurry vision did not last as long but his nausea and dizziness lasted for 3 to 4 hours.
Age: 37.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Vision blurred
Clinical narrative: blurry vision; extreme dizziness; felt clammy; really bad reaction; headache,; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart disorder.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction), HEADACHE (headache,) and NAUSEA (nausea). At the time of the report, VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness) and NAUSEA (nausea) had resolved and COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Aug-2021, Heart rate: increased (High) High heart rate for 15 minutes..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided. Three minutes after the first dose, really bad reaction with high heart rate for 15 minutes, blurry vision, headache, nausea, extreme dizziness was reported. The patient was not sweating but felt clammy. The patient stated that his blurry vision did not last as long but his nausea and dizziness lasted for 3 to 4 hours.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Skin discolouration
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of skin discolouration (black and blue in some spots), erythematous rash (mainly red) and rash all over her body in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced skin discolouration (black and blue in some spots), erythematous rash (mainly red) and rash all over her body. At the time of the report, skin discolouration (black and blue in some spots), erythematous rash (mainly red) and rash all over her body: not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Patient getting worse and worse. Reporter said the Moderna vaccine caused a complete reaction/rash and she greatly  suffered. Concomitant medications and treatment information not provided.